In 2023, mortality due to trachea, bronchus, or lung malignant neoplasms in Japan stood at an estimated 76.90 thousand deaths. Forecasts predict a gradual increase over the next five years, reaching 78.95 thousand by 2028. From 2024 to 2025, the year-on-year mortality increase is 0.54%, followed by 0.53% for each of the subsequent years through 2028. The compound annual growth rate (CAGR) over this period is approximately 0.52%, indicating a steady upward trend in mortality related to these conditions.
Future trends to watch include advances in medical treatment and early detection practices which may alter this trajectory. Additionally, shifts in smoking prevalence and public health initiatives aimed at lung health could impact future mortality rates.
